spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  AMITIZA 

 HSMN NewsFeed - 4 Jan 2021
Endo Launches Authorized Generic Version of Amitiza(R) (lubiprostone) Capsules in the United States
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 28 May 2019
Mallinckrodt Updates Plans for Company Separation and Spin-Off of Specialty Generics Business to Shareholders
Biopharmaceuticals Generics
 HSMN NewsFeed - 21 May 2019
Mallinckrodt Files Suit against U.S. Department of Health and Human Services (HHS) and Centers for Medicare and Medicaid Services (CMS) to Protect Medicaid Patient Access to Acthar(R) Gel
Biopharmaceuticals Reimbursement Litigation
 HSMN NewsFeed - 6 May 2019
Mallinckrodt Announces Encouraging Interim Analysis Results in Phase 4 Registry of INOmax(R) (Nitric Oxide) Gas for Inhalation for Pulmonary Hypertension in Neonates
Biopharmaceuticals
 HSMN NewsFeed - 15 Apr 2019
Data on Impact of Revised Consensus Recommendations on Time to Treatment and Serum Creatinine (SCr) at Treatment Start for Patients with Hepatorenal Syndrome Type 1 (HRS-1) Presented at the 2019 International Liver Congress(TM) (EASL)
Biopharmaceuticals
 HSMN NewsFeed - 12 Apr 2019
Mallinckrodt Completes Full Enrollment of its Phase 3 Clinical Trial for StrataGraft(R) Regenerative Skin Tissue
Devices Regenerative Medicine Wound Care
 HSMN NewsFeed - 18 Mar 2019
Bryan Reasons Joins Mallinckrodt as the Company's Chief Financial Officer (CFO)
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Feb 2018
Mallinckrodt Completes Acquisition Of Sucampo Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Dec 2017
Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Apr 2017
Sucampo Acquires Vtesse Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Jul 2016
Takeda and TiGenix Enter into Licensing Agreement for Ex-U.S. Rights to Cx601 for the Treatment of Complex Perianal Fistulas in Patients with Crohn's Disease
Biopharmaceuticals Regenerative Medicine Licensing
 HSMN NewsFeed - 13 Oct 2015
Timothy P. Walbert Joins Sucampo's Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jul 2014
Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction
Biopharmaceuticals Generics Acquisitions
 HSMN NewsFeed - 20 Jun 2012
Sucampo Appoints Dipak Panigrahi, MS, MD, as Vice President, Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Sep 2008
Sucampo Pharmaceuticals Limited Appoints New Head of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Aug 2008
Sucampo Pharmaceuticals Announces Key Management and Board Appointments at its European Affiliate
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 May 2008
AMITIZA(R) (lubiprostone) 8 mcg Now Available to Treat Irritable Bowel Syndrome with Constipation in Adult Women
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 27 Feb 2008
Sucampo Pharma Europe Announces the Filing of a Marketing Authorisation Application of Lubiprostone in the United Kingdom with Eight Additional European Countries to Follow
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 Feb 2008
Sucampo Pharmaceuticals Appoints John C. Wright, Retired Ernst & Young Partner, to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Feb 2008
Sucampo Pharmaceuticals Expands Global Presence as European Subsidiary Opens New Office in Basel, Switzerland
Biopharmaceuticals
 HSMN NewsFeed - 24 Oct 2007
Sucampo Pharmaceuticals Announces CFO Transition in 2008; Elects New Independent Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2007
Sucampo Pharmaceuticals Presents Data on Cobiprostone at American College of Gastroenterology Annual Scientific Meeting
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 13 Sep 2007
Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
Biopharmaceuticals
 HSMN NewsFeed - 21 May 2007
New Study Demonstrates That Lubiprostone May Improve Symptom Relief Rates in Adults With Irritable Bowel Syndrome With Constipation (IBS-C)
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 15 May 2007
Array BioPharma Appoints John Yates, MB ChB, MD, to Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Feb 2007
Takeda and TAP to Promote Sucampo's AMITIZA(R) in the United States
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 19 Jan 2007
Takeda Global Research & Development Center, Inc. Names Dr. Mehmood Khan President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2007
Sucampo Appoints Veteran Financial Executive Ronald W. Kaiser as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Oct 2006
AMITIZA(TM) (lubiprostone) Phase III Constipation Trial Results Demonstrate Improvements in Symptoms of Irritable Bowel Syndrome With Constipation
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 3 Oct 2006
Sucampo Pharmaceuticals Completes Planned Consolidation of European and Asian Affiliates; Announces Strategic Alignment of Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 May 2006
New Study Demonstrates That AMITIZA(TM) (lubiprostone) May Help Improve Symptoms of Irritable Bowel Syndrome With Constipation
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 21 May 2006
AMITIZA(TM) (Lubiprostone) Shown Effective and Well-Tolerated in People Older than Age 65, a Population Considerably Affected by Chronic Idiopathic Constipation
Biopharmaceuticals Gastroenterology
Return to NewsFeed  

 Additional items found! 2

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 2 additional stories matching:
AMITIZA
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!